Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice

Published:2021-05 Issue: Volume:167 Page:105537
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Fogli Stefano^ORCID,Galimberti Sara,Gori Veronica,Del Re Marzia,Danesi Romano^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference92 articles.

1. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy;Zhang;Pharmacol. Res.,2020

2. The ubiquitin-proteasome system and its crosstalk with mitochondria as therapeutic targets in medicine;Kodron;Pharmacol. Res.,2021

3. Proteasome inhibitors: an expanding army attacking a unique target;Kisselev;Chem. Biol.,2012

4. A practical review of proteasome pharmacology;Thibaudeau;Pharm. Rev.,2019

5. The proteasome as a druggable target with multiple therapeutic potentialities: cutting and non-cutting edges;Tundo;Pharmacol. Ther.,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome Inhibitors in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

2. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08

3. Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model;Fluids and Barriers of the CNS;2023-10-06

4. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review;Medical Oncology;2023-09-09

5. Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives;Journal of Personalized Medicine;2023-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3